Nature Communications (Feb 2022)

Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines

  • Svenja Weiss,
  • Vincenza Itri,
  • Ruimin Pan,
  • Xunqing Jiang,
  • Christina C. Luo,
  • Lynn Morris,
  • Delphine C. Malherbe,
  • Philip Barnette,
  • Jeff Alexander,
  • Xiang-Peng Kong,
  • Nancy L. Haigwood,
  • Ann J. Hessell,
  • Ralf Duerr,
  • Susan Zolla-Pazner

DOI
https://doi.org/10.1038/s41467-022-28450-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

Here the authors show that an HIV vaccine in non-human primates that focuses antibodies on the V1V2 region of gp120 is superior to infection or immunization with whole envelope vaccines for inducing V1V2 antibodies with anti-viral functions that correlate with protection.